This Definium Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Kanzhun Ltd. Sponsored ADR
Kite Realty Group Trust
Ramaco Resources-A
Ameresco, Inc. Class A
Definium Therapeutics, Inc.
Kanzhun Ltd. Sponsored ADR BZ | 0.00 | |
Kite Realty Group Trust KRG | 0.00 | |
Ramaco Resources-A METC | 0.00 | |
Ameresco, Inc. Class A AMRC | 0.00 | |
Definium Therapeutics, Inc. DFTX | 0.00 |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- B of A Securities analyst Tazeen Ahmad initiated coverage on Definium Therapeutics Inc (NASDAQ:DFTX) with a Buy rating and announced a price target of $75. Definium Therapeutics closed at $45.26 on Monday. See how other analysts view this stock.
- B of A Securities analyst Miranda Zhuang initiated coverage on Kanzhun Ltd (NASDAQ:BZ) with a Neutral rating and announced a price target of $74. Kanzhun shares closed at $15.55 on Monday. See how other analysts view this stock.
- Canaccord Genuity analyst Peter Bell initiated coverage on Sinda Ltd (NYSE:SIND) with a Speculative Buy rating and announced a price target of $19. Sinda closed at $16.69 on Monday. See how other analysts view this stock.
- Chardan Capital analyst Andreas Argyrides initiated coverage on Rani Therapeutics Holdings Inc (NASDAQ:RANI) with a Buy rating and announced a price target of $6. Rani Therapeutics shares closed at $0.80 on Monday. See how other analysts view this stock.
- Canaccord Genuity analyst Dalton Baretto initiated coverage on Sunshine Silver Mining & Refining Co (NYSE:SSMR) with a Speculative Buy rating and announced a price target of $20. Sunshine Silver Mining closed at $16.00 on Monday. See how other analysts view this stock.
Considering buying DFTX stock? Here’s what analysts think:
Photo via Shutterstock